The maximum retail prices of the three anti-cancer drugs (Trastuzumab, Osimertinib and Durvalumab) will come down due to customs duty waiver and reduction in GST rates
In line with the government's commitment to ensure availability of affordable medicines, the National Pharmaceutical Pricing Authority (NPPA) issued an...